BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31124485)

  • 1. Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center.
    Shields CL; Udyaver S; Dalvin LA; Lim LS; Atalay HT; L Khoo CT; Mazloumi M; Shields JA
    Indian J Ophthalmol; 2019 Jun; 67(6):772-783. PubMed ID: 31124485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coats Disease: Clinical Features and Outcomes by Age Category in 351 Cases.
    Dalvin LA; Udyaver S; Lim LS; Mazloumi M; Atalay HT; Khoo CTL; Shields CL
    J Pediatr Ophthalmol Strabismus; 2019 Sep; 56(5):288-296. PubMed ID: 31545862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
    Ramasubramanian A; Shields CL
    Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.
    Li S; Deng G; Liu J; Ma Y; Lu H
    BMC Ophthalmol; 2017 May; 17(1):76. PubMed ID: 28532448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Coats' Disease With Combination Therapy of Intravitreal Bevacizumab, Laser Photocoagulation, and Sub-Tenon Corticosteroids.
    Sein J; Tzu JH; Murray TG; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2016 May; 47(5):443-9. PubMed ID: 27183548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab injections combined with laser photocoagulation for adult-onset Coats' disease.
    Park S; Cho HJ; Lee DW; Kim CG; Kim JW
    Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1511-1517. PubMed ID: 26631136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coats-like Exudative Vitreoretinopathy in Retinitis Pigmentosa: Ocular Manifestations and Treatment Outcomes.
    Moinuddin O; Sathrasala S; Jayasundera KT; Branham KH; Chang EY; Qian CX; Recchia FM; Fahim AT; Besirli CG
    Ophthalmol Retina; 2021 Jan; 5(1):86-96. PubMed ID: 32507488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant anti-VEGF therapy in Coats' disease].
    Fiorentzis M; Stavridis E; Seitz B; Viestenz A
    Ophthalmologe; 2015 May; 112(5):451-4. PubMed ID: 25134462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRANSCLERAL DRAINAGE OF SUBRETINAL FLUID, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR, AND WIDE-FIELD IMAGING-GUIDED LASER IN COATS EXUDATIVE RETINAL DETACHMENT.
    Stanga PE; Jaberansari H; Bindra MS; Gil-Martinez M; Biswas S
    Retina; 2016 Jan; 36(1):156-62. PubMed ID: 26355946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF COATS DISEASE IN A SAUDI ARABIAN POPULATION.
    Al-Qahtani AA; Almasaud JM; Ghazi NG
    Retina; 2015 Oct; 35(10):2091-9. PubMed ID: 25978728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of stage 3B Coats disease: presentation of a combined treatment modality and long-term follow-up.
    Liang T; Peng J; Zhang Q; Zhu X; Xu Y; Zhao P
    Graefes Arch Clin Exp Ophthalmol; 2020 Sep; 258(9):2031-2038. PubMed ID: 32474693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Visual Outcomes in Coats' Disease: A 20-Year Experience.
    Ong SS; Buckley EG; McCuen BW; Jaffe GJ; Postel EA; Mahmoud TH; Stinnett SS; Toth CA; Vajzovic L; Mruthyunjaya P
    Ophthalmology; 2017 Sep; 124(9):1368-1376. PubMed ID: 28461016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats' disease.
    Zhang L; Ke Y; Wang W; Shi X; Hei K; Li X
    Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1339-1346. PubMed ID: 29549425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease.
    Bhat V; D'Souza P; Shah PK; Narendran V
    Middle East Afr J Ophthalmol; 2016; 23(2):208-11. PubMed ID: 27162454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment for Coats' disease: retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases.
    Kodama A; Sugioka K; Kusaka S; Matsumoto C; Shimomura Y
    BMC Ophthalmol; 2014 Mar; 14():36. PubMed ID: 24666524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coats' disease: characteristics, management, outcome, and scleral external drainage with anterior chamber maintainer for stage 3b disease.
    Yousef YA; ElRimawi AH; Nazzal RM; Qaroot AF; AlAref AH; Mohammad M; Abureesh O; Rejdak R; Nowomiejska K; Avitabile T; Toro MD; AlNawaiseh I
    Medicine (Baltimore); 2020 Apr; 99(16):e19623. PubMed ID: 32311932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Predictive of Subretinal Fluid Resolution in Coats Disease: Analysis of 177 Eyes in 177 Patients at a Single Center.
    Khoo CTL; Dalvin LA; Lim LS; Mazloumi M; Atalay HT; Udyaver S; Shields JA; Shields CL
    Asia Pac J Ophthalmol (Phila); 2019; 8(4):290-297. PubMed ID: 31356365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination treatment of pediatric coats' disease: a bicenter study in Taiwan.
    Lin CJ; Chen SN; Hwang JF; Yang CM
    J Pediatr Ophthalmol Strabismus; 2013; 50(6):356-62. PubMed ID: 24669373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coats disease: An overview of classification, management and outcomes.
    Sen M; Shields CL; Honavar SG; Shields JA
    Indian J Ophthalmol; 2019 Jun; 67(6):763-771. PubMed ID: 31124484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Coats' disease with intravitreal bevacizumab.
    Ray R; Barañano DE; Hubbard GB
    Br J Ophthalmol; 2013 Mar; 97(3):272-7. PubMed ID: 23269680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.